STAT3 Gene - Signal Transducer and Activator of Transcription 3

A critical transcription factor in cytokine signaling, immunity, and cancer

Gene Information Card

Symbol STAT3
Full Name Signal transducer and activator of transcription 3
Gene Type Protein coding
Chromosomal Location 17q21.2
NCBI Gene ID 6774 ncbi.nlm.nih.gov/gene/6774
Ensembl ID ENSG00000168610
UniProt ID P40763
OMIM ID 102582
HGNC ID 11364
Aliases APRF, HIES, ADMIO, MGC17067

Description

The STAT3 gene encodes a transcription factor that mediates cellular responses to various cytokines and growth factors. It plays a central role in immune regulation, cell proliferation, differentiation, and survival. STAT3 is activated by phosphorylation via JAK kinases in response to interleukins (e.g., IL-6, IL-10) and growth factors, leading to dimerization, nuclear translocation, and target gene transcription. Dysregulation of STAT3 signaling is implicated in numerous diseases, including immunodeficiencies, autoimmune disorders, and cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autosomal dominant hyper-IgE syndrome (Job syndrome) Loss-of-function mutations in STAT3 impair Th17 cell differentiation and IL-6/IL-10 signaling, leading to recurrent infections, eczema, and skeletal abnormalities. OMIM #147060; ClinVar
Autoimmune diseases (e.g., rheumatoid arthritis, inflammatory bowel disease) Gain-of-function mutations or overactivation of STAT3 promote pro-inflammatory cytokine production and T-cell dysregulation. OMIM #102582; PubMed
Various cancers (e.g., breast, lung, colorectal, lymphoma) Constitutive activation of STAT3 (via phosphorylation) drives oncogenic gene expression, promoting proliferation, survival, angiogenesis, and immune evasion. COSMIC; PubMed
STAT3-related early-onset multisystem autoimmune disease Gain-of-function mutations in STAT3 cause lymphoproliferation, autoimmune cytopenias, and interstitial lung disease. OMIM #615952; ClinVar
Hepatocellular carcinoma STAT3 activation in liver cells promotes tumor growth and metastasis through upregulation of anti-apoptotic and proliferative genes. COSMIC; PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 20.1 High
Bone marrow 15.3 Medium
Lung 12.8 Medium
Spleen 11.5 Medium
Kidney 9.2 Low
Brain 6.4 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 25.3 High expression; constitutive activation in CML
HeLa (cervical cancer) 18.7 Moderate; responsive to IL-6
A549 (lung cancer) 22.1 High; associated with oncogenic signaling
MCF7 (breast cancer) 14.5 Moderate; estrogen receptor positive
HepG2 (liver cancer) 19.8 High; involved in acute phase response
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
R382W Missense Rare (germline) Loss-of-function; associated with hyper-IgE syndrome
V637M Missense Rare (germline) Gain-of-function; causes autoimmune disease
D661Y Missense Somatic (cancer) Gain-of-function; constitutive activation in various tumors
K658N Missense Somatic (cancer) Gain-of-function; promotes oncogenic transcription
Y705F Missense Somatic (cancer) Loss of phosphorylation site; dominant-negative effect
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in STAT3, typically in the DNA-binding or SH2 domains, impair its transcriptional activity, leading to immunodeficiency (e.g., hyper-IgE syndrome) and defective Th17 cell differentiation.

Gain of Function (GOF)

Gain-of-function mutations, often in the SH2 domain or C-terminal region, enhance STAT3 activation and nuclear signaling, resulting in autoimmune disorders and oncogenic transformation.

Dominant Negative (DN)

Dominant-negative mutations produce a STAT3 protein that can dimerize with wild-type STAT3 but lacks transcriptional activity, thereby suppressing normal signaling. These are commonly seen in hyper-IgE syndrome.

Gene Ontology (GO)

• DNA-binding transcription factor activity • RNA polymerase II cis-regulatory region sequence-specific DNA binding
• Signal transducer activity • Protein homodimerization activity
• Cytokine receptor binding • Kinase binding
• Transcription coregulator binding • Nucleus
• Cytoplasm • Cellular response to cytokine stimulus
• Regulation of cell population proliferation • Inflammatory response
• Immune response

Pathways

JAK-STAT signaling pathway
IL-6 signaling pathway
IL-10 signaling pathway
IL-23 signaling pathway
PD-L1 expression and PD-1 checkpoint pathway in cancer
Th17 cell differentiation
Acute phase response
EGFR tyrosine kinase inhibitor resistance

Protein Summary

STAT3 is a 770-amino acid protein with a molecular weight of ~88 kDa. It contains conserved domains: an N-terminal domain, a coiled-coil domain, a DNA-binding domain, a SH2 domain, and a C-terminal transactivation domain. Upon cytokine stimulation, JAK kinases phosphorylate STAT3 at tyrosine 705, inducing dimerization and nuclear translocation. In the nucleus, STAT3 binds to specific DNA response elements to regulate gene expression. STAT3 also undergoes acetylation and phosphorylation at serine 727, modulating its activity. It interacts with various coactivators and corepressors, influencing a wide range of biological processes.

Related Products

Product name Cat.No. Species Gene ID
STAT3 Knockout HEK293 Cell Line EDJ-KQ903 Human 6774 Details Get a Quote
STAT3 Knockout HeLa Cell Line EDJ-KQ18072 Human 6774 Details Get a Quote
STAT3 Knockout A-549 Cell Line EDJ-KQ21087 Human 6774 Details Get a Quote
STAT3 Knockout HCT 116 Cell Line EDJ-KQ21089 Human 6774 Details Get a Quote
Stat3 Knockout CT26.WT Cell Line EDJ-KZ496 Mouse 20848 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: